News and Announcements
MedAdvisor AGM CEO Presentation
- Published October 27, 2016 12:24PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th October 2016, ASX Announcement
FY16 Results Overview
- Total revenue of $1.76m, representing a 24% increase on FY15 on a normalised basis
– Normalised basis excludes a final license fee payment of $500,000 from FY15 revenue of $1.9 million - Revenue from pharmacy subscriptions and patient engagement programs (PEP) up 24% to $1.43 million
– Additional revenue streams expected to go live during FY17 - Gross profit of $925k, up 133% on FY15
- Gross margin from pharmacy subscriptions increased to 71%, from 43% in the prior corresponding period
- Net loss of $3.07 million due to increased costs and investments in expanding marketing and sales initiatives for further expansion in FY17
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
